Novo Nordisk Foundation pumps $136M into new clinical cell therapy manufacturing 'hub' in Denmark Looking to establish a “hub” in the cell therapy ecosystem, the Novo Nordisk Foundation is pumping 950 million Danish kroner (about $136 million) into a new clinical production site at the Technical University of Denmark (DTU) in Lyngby. Log in or register to post comments
